As filed with the Securities and Exchange Commission on _________, 1998.
                                                        Registration No. 333-
-----------------------------------------------------------------------------
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
                                --------------------
                                     FORM S-8
                REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                --------------------
                              SEROLOGICALS CORPORATION
                 (Exact name of issuer as specified in its charter)
            Delaware                                  58-2142225  
(State or other jurisdiction of            (I.R.S. Employer Identification 
incorporation or organization)                             Number)         

                         780 Park North Blvd., Suite 110
                             Clarkston, Georgia 30021
                  (Address of principal executive offices) (Zip Code)
                                --------------------
                                                    
                       OPTION AGREEMENTS WITH VARIOUS INDIVIDUALS
                               (Full titles of the Plans)
                                  
                                 Harold J. Tenoso, Ph.D.
                          President and Chief Executive Officer
                                Serologicals Corporation
                             780 Park North Blvd., Suite 110
                                Clarkston, Georgia 30021
                                      (404) 296-5595
                           (Name, address and telephone number,
                         including area code, of agent for service)
                                         Copies to:
                                    David S. Rosenthal, Esq.
                            Shereff, Friedman, Hoffman & Goodman, LLP
                                       919 Third Avenue
                                New York, New York  10022
                                       (212) 758-9500
                             CALCULATION OF REGISTRATION FEE


                                                      Proposed
  Title of          Amount            Proposed         Maximum
 Securities         to be              Maximum        Aggregate   Amount of 
    to be        Registered(1)        Offering        Offering   Registration
 Registered       Per Share             Price           Price        Fee
-------------   --------------       ----------      ----------  ------------

Common Stock,
par value        255,000 shares       $19.00(2)     $4,755,000(2)  $1,402.73
$0.01 per share

(1)  Pursuant to Rule 416, this Registration Statement also covers such 
additional securities as may become issuable to prevent dilution resulting from 
stock splits, stock dividends or similar transactions.

(2)  Estimated solely for the purpose of calculating the registration fee 
pursuant to Rule 457(h), with options for 195,000 shares having been granted at 
an exercise price of $19.00 per share and options for 60,000 shares having been 
granted at an exercise price of $17.50 per share. 

<PAGE>

                                     PART II

                               INFORMATION REQUIRED IN
                              THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

     The following documents, which have been filed by Serologicals Corporation 
a Delaware corporation (the "Registrant"), with the Securities and Exchange 
Commission (the "Commission"), are incorporated herein by reference:

     (a) The Registrant's Annual Report on Form 10-K for the period ended 
December 31, 1996.

     (b) The Registrant's Quarterly Report on Form 10-Q for the period ended 
March 31, 1997.

     (c) The Registrant's Quarterly Report on Form 10-Q for the period ended 
June 30, 1997.

     (d) The Registrant's Quarterly Report on Form 10-Q for the period ended 
September 30, 1997.

     (e) The description of the Registrant's Common Stock, par value $0.01 per 
share, which is contained in a registration statement filed under Section 12 of 
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including 
any amendment or report filed for the purpose of updating such description.

     In addition, all documents subsequently filed by the Registrant pursuant 
to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing 
of a post-effective amendment which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold, shall be 
deemed to be incorporated by reference in this registration statement and to be
a part hereof from the time of filing of such documents.  Any statement 
contained in the documents incorporated or deemed to be incorporated by 
reference herein shall be deemed to be modified or superseded for purposes of 
this registration statement to the extent that a statement contained herein or 
in any other subsequently filed document which also is incorporated or deemed 
to be incorporated by reference herein modifies or supersedes such statement.  
Any such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this registration statement.

Item 4.  Description of Securities.

Not applicable.

Item 5.  Interest of Named Experts and Counsel. 

Not applicable.

Item 6.  Indemnification of Directors and Officers.

    The indemnification of officers and directors of the Registrant is governed 
by Section 145 of the General Corporation Law of the State of Delaware (the 

<PAGE>

"DGCL") and the Amended and Restated Certificate of Incorporation of the 
Registrant. Among other things, the DGCL permits indemnification of a director, 
officer, employee or agent in civil, criminal, administrative or investigative 
actions, suits or proceedings (other than an action by or in the right of the 
corporation) to which such person is a party or is threatened to be made a 
party by reason of the fact of such relationship with the corporation or the 
fact that such person is or was serving in a similar capacity with another 
entity at the request of the corporation against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him if such person acted in good faith and in a manner he 
reasonably believed to be in or not opposed to the best interests of the 
corporation, and, with respect to any criminal action or proceeding, if he had
no reasonable cause to believe his conduct was unlawful. No indemnification may
be made in any such suit to any person adjudged to be liable to the corporation
unless and only to the extent that the Delaware Court of Chancery or the court
in which the action was brought determines that, despite the adjudication of 
liability, such person is under all circumstances, fairly and reasonably 
entitled to indemnity for such expenses which such court shall deem proper.  
Under the DGCL, to the extent that a director, officer, employee or agent is 
successful, on the merits or otherwise, in the defense of any action, suit or 
proceeding or any claim, issue or matter therein (whether or not the suit is 
brought by or in the right of the corporation), he shall be indemnified against
expenses (including attorneys' fees) actually and reasonably incurred by him. 
In all cases in which indemnification is permitted (unless ordered by a court),
it may be made by the corporation only as authorized in the specific case upon 
a determination that the applicable standard of conduct has been met by the 
party to be indemnified.  The determination must be made by a majority vote of 
a quorum consisting of the directors who were not parties to the action or, if 
such a quorum is not obtainable, or even if obtainable, if a quorum of dis-
interested directors so directs, by independent legal counsel in a written 
opinion, or by the shareholders.  The statute authorizes the corporation to pay
expenses incurred by an officer or director in advance of a final disposition 
of a proceeding upon receipt of an undertaking by or on behalf of the person to
whom the advance will be made, to repay the advances if it shall ultimately be 
determined that he was not entitled to indemnification.  The DGCL provides that
indemnification and advancement of expenses permitted thereunder are not to be 
exclusive of any rights to which those seeking indemnification or advancement 
of expenses may be entitled under any By-law, agreement, vote of stockholders 
or disinterested directors, or otherwise.  The DGCL also authorizes the 
corporation to purchase and maintain liability insurance on behalf of its 
directors, officers, employees and agents regardless of whether the corporation
would have the statutory power to indemnify such persons against the 
liabilities insured.

     The Amended and Restated Certificate of Incorporation of the Registrant, 
as amended (the "Certificate"), provides that no director of the Registrant 
shall be personally liable to the Registrant or its stockholders for monetary
damages for breach of fiduciary duty as a director except for liability (i) for
any breach of the director's duty of loyalty to the Registrant or its stock-
holders, (ii) for acts or omissions not in good faith or which involve 
intentional misconduct or a knowing violation of law, (iii) for paying a 
dividend or approving a stock repurchase in violation of Section 174 of the 
DGCL or (iv) for any transaction from which the director derived an improper 
personal benefit.


     In addition, the Certificate provides that directors, officers and others 
shall be indemnified to the fullest extent authorized by the DGCL, as in effect 
(or, to the extent indemnification is broadened, as it may be amended), against 
any and all expense, liability and loss (including settlement) reasonably 
incurred or suffered by such person in connection with such service.  The 
Certificate further provides that, to the extent permitted by law, expenses so 
incurred by any such person in defending any such proceeding shall, at his 

<PAGE>

request, be paid by the Registrant in advance of the final disposition of such 
action or proceeding.

     The Certificate provides that the right to indemnification and the payment 
of expenses incurred in defending a proceeding in advance of its final 
disposition shall not be exclusive of any other right which any person may have 
or acquire under any law, provision of By-laws or otherwise.

     Pursuant to indemnification agreements with certain of its executive 
officers and directors the Registrant has agreed to indemnify such persons 
(including their respective heirs, executors and administrators) to the fullest 
extent permitted by the DGCL against all expenses and liabilities reasonably 
incurred in connection with or arising out of any action, suit or proceeding in 
which such executive officer or director may be involved by reason of having 
been a director or officer of the Registrant or any subsidiary thereof.

     The Registrant maintains directors and officers liability and company 
reimbursement insurance which, among other things (i) provides for payment on 
behalf of its officers and directors against loss as defined in the policy 
stemming from acts committed by directors and officers in their capacity as 
such and (ii) provides for payment on behalf of the Registrant against such 
loss but only when the Registrant shall be required or permitted to indemnify 
directors or officers for such loss pursuant to statutory or common law or 
pursuant to duly effective certificate of incorporation or by-law provisions.

Item 7.  Exemption from Registration Claimed.

         Not Applicable.

Item 8.  Exhibits

         The following exhibits are filed as part of this registration 
statement:

         4.1   Form of Option Agreement

         5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

        23.1   Consent of Arthur Andersen LLP.

        23.2   Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included
               in Exhibit 5.1).

        24     Power of Attorney (included in signature page to this 
               registration statement).

Item 9. Undertakings.

         (a)   The undersigned Registrant hereby undertakes:

<PAGE>

              (1) To file, during any period in which offers or sales are being 
          made, a post-effective amendment to this registration statement:

                  (i)  To include any prospectus required by section 10(a)(3) 
                       of the Securities Act of 1933;

                  (ii) To reflect in the prospectus any facts or events arising 
                       after the effective date of the registration statement 
                       (or the most recent post effective amendment thereof) 
                       which, individually or in the aggregate, represent a 
                       fundamental change in the information set forth in the 
                       registration statement.  Notwithstanding the foregoing, 
                       any increase or decrease in volume of securities offered 
                       (if the total dollar value of securities offered would 
                       not exceed that which was registered) and any deviation 
                       from the low or high end of the estimated maximum 
                       offering range may be reflected in the form of 
                       prospectus filed with the Commission pursuant to Rule 
                       424(b) if, in the aggregate, the change in volume and 
                       price represent no more than a 20% change in the maximum
                       aggregate offering price set forth in the "Calculation 
                       of Registration Fee" table in the effective registration
                       statement;

                 (iii) To include any material information with respect to the 
                       plan of distribution not previously disclosed in the 
                       registration statement or any material change to such 
                       information in the registration statement;

     provided, however, that paragraphs (a)(l)(i) and (ii) do not apply if the 
     registration statement is on Form S-3 or S-8 and the information required 
     to be included in a post-effective amendment by those paragraphs is 
     contained in periodic reports filed by the Registrant pursuant to section 
     13 or Section 15(d) of the Securities Exchange Act of 1934 that are 
     incorporated by reference in the registration statement. 

         (2) That, for the purpose of determining any liability under the 
     Securities Act of 1933, each such post-effective amendment shall be deemed 
     to be a new registration statement relating to the securities offered 
     therein, and the offering of such securities at that time shall be deemed 
     to be the initial bona fide offering thereof.

         (3) To remove from registration by means of a post-effective amendment 
     any of the securities being registered which remain unsold at the 
     termination of the offering.

     (b)  The undersigned Registrant hereby undertakes that, for the purposes 
of determining any liability under the Securities Act of 1933, each filing of 
the Registrant's annual report pursuant to Section 13(a) or 15(d) of the 
Securities Exchange Act of 1934 (and, where applicable, each filing of an 
employee benefit plan's annual report pursuant to Section 15(d) of the 
Securities Exchange Act of 1934) that is incorporated by reference in the 
registration statement shall be deemed to be a new registration statement 
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.


     (h)  Insofar as indemnification for liabilities arising under the 
Securities Act of 1933 may be permitted to directors, officers and controlling 
persons of the Registrant pursuant to the foregoing provisions, or otherwise, 
the Registrant has been advised that in the opinion of the Securities and 

<PAGE>

Exchange Commission such indemnification is against public policy as expressed 
in the Act and is, therefore, unenforceable. In the event that a claim for 
indemnification against such liabilities (other than the payment by the 
Registrant of expenses incurred or paid by a director, officer or controlling 
person of the Registrant in the successful defense of any action, suit or 
proceeding) is asserted by such director, officer or controlling person in 
connection with the securities being registered, the Registrant will, unless in 
the opinion of its counsel the matter has been settled by controlling 
precedent, submit to a court of appropriate jurisdiction the question whether 
such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue. 


<PAGE>


                                     SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant 
certifies that it has reasonable grounds to believe that it meets all the 
requirements for filing on Form S-8 and has duly caused this Registration 
Statement to be signed on its behalf by the undersigned, hereunto duly 
authorized, in the City of Clarkston, State of Georgia, on this 5th day of 
March, l998.

                                              SEROLOGICALS CORPORATION

                                              By: /s/ Harold J. Tenoso       
                                                 -----------------------
                                                 Harold J. Tenoso, Ph.D.
                                                 President, Chief Executive 
                                                 Officer and Director

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned whose 
signature appears below constitutes and appoints Harold J. Tenoso, Ph.D. and 
Russell H. Plumb, and each of them (with full power of each of them to act 
alone), his true and lawful attorneys-in-fact, with full power of substitution 
and resubstitution for him and on his behalf, and in his name, place and stead, 
in any and all capacities to execute and sign any and all amendments or post-
effective amendments to this registration statement, and to file the same, with 
all exhibits thereto, and other documents in connection therewith, with the 
Securities and Exchange Commission, hereby ratifying and confirming all that 
said attorneys-in-fact or any of them or their or his substitute or 
substitutes, may lawfully do or cause to be done by virtue hereof and the 
Registrant hereby confers like authority on its behalf.

     Pursuant to the requirements of the Securities Act of 1933, the 
Registration Statement has been signed below by the following persons on behalf 
of the Registrant and in the capacities and on the dates indicated.

      Signature                     Title                       Date

/s/ Harold J. Tenoso       President, Chief Executive Officer  
Harold J. Tenoso, Ph.D.    and Director (Principal Executive  March 5, 1998
                            Officer

/s/ Samuel A. Penninger    Chairman of the Board of Directors  
Samuel A. Penninger, Jr.                                      March 5, 1998

/s/ James L. Currie        Director         
James L. Currie                                               March 5, 1998

/s/ Wade Fetzer            Director         
Wade Fetzer III                                               March 5, 1998

/s/ George M. Shaw         Director         
George M. Shaw                                                March 5, 1998

/s/ Lawrence E. Tilton     Director         
Lawrence E. Tilton                                            March 5, 1998

/s/ Matthew C. Weisman     Director         
Matthew C. Weisman                                            March 5, 1998

/s/Russell H. Plumb        Vice President, Finance and
Russell H. Plumb           and Administration and Chief       March 5, 1998
                           Financial Officer (Principal
                           Financial and Accounting Officer)

<PAGE>

                       SEROLOGICALS CORPORATION
                             FORM S-8
                        REGISTRATION STATEMENT

                            EXHIBIT INDEX
                            -------------
                                                                Sequentially
                                                                Numbered
Exhibit                                                         Page
                                                                
4.1   Form of Option Agreement.

5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

23.1  Consent of Arthur Andersen LLP.

23.2  Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included in 
      Exhibit 5.1).

24    Power of Attorney (included in signature page to this registration 
      statement).


<PAGE>
[{"type": "S-8", "sequence": "1", "secsgml_size_bytes": 21392}]
{"company-data": {"conformed-name": "SEROLOGICALS CORP", "cik": "0000767673", "assigned-sic": "2836", "irs-number": "582142225", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-47433", "film-number": "98558852"}, "business-address": {"street1": "780 PARK NORTH BLVD", "street2": "STE 110", "city": "CLARKSTON", "state": "GA", "zip": "30021", "phone": "4042965595"}, "mail-address": {"street1": "780 PARK NORTH BLVD", "street2": "STE 110", "city": "CLARKSTON", "state": "GA", "zip": "30021"}, "former-company": {"former-conformed-name": "SEROLOGICALS HOLDINGS INC", "date-changed": "19950418"}}
As filed with the Securities and Exchange Commission on _________, 1998.
                                                        Registration No. 333-
-----------------------------------------------------------------------------
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
                                --------------------
                                     FORM S-8
                REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                --------------------
                              SEROLOGICALS CORPORATION
                 (Exact name of issuer as specified in its charter)
            Delaware                                  58-2142225  
(State or other jurisdiction of            (I.R.S. Employer Identification 
incorporation or organization)                             Number)         

                         780 Park North Blvd., Suite 110
                             Clarkston, Georgia 30021
                  (Address of principal executive offices) (Zip Code)
                                --------------------
                                                    
                       OPTION AGREEMENTS WITH VARIOUS INDIVIDUALS
                               (Full titles of the Plans)
                                  
                                 Harold J. Tenoso, Ph.D.
                          President and Chief Executive Officer
                                Serologicals Corporation
                             780 Park North Blvd., Suite 110
                                Clarkston, Georgia 30021
                                      (404) 296-5595
                           (Name, address and telephone number,
                         including area code, of agent for service)
                                         Copies to:
                                    David S. Rosenthal, Esq.
                            Shereff, Friedman, Hoffman & Goodman, LLP
                                       919 Third Avenue
                                New York, New York  10022
                                       (212) 758-9500
                             CALCULATION OF REGISTRATION FEE

                                                      Proposed
  Title of          Amount            Proposed         Maximum
 Securities         to be              Maximum        Aggregate   Amount of 
    to be        Registered(1)        Offering        Offering   Registration
 Registered       Per Share             Price           Price        Fee
-------------   --------------       ----------      ----------  ------------

Common Stock,
par value        255,000 shares       $19.00(2)     $4,755,000(2)  $1,402.73
$0.01 per share

(1)  Pursuant to Rule 416, this Registration Statement also covers such 
additional securities as may become issuable to prevent dilution resulting from 
stock splits, stock dividends or similar transactions.

(2)  Estimated solely for the purpose of calculating the registration fee 
pursuant to Rule 457(h), with options for 195,000 shares having been granted at 
an exercise price of $19.00 per share and options for 60,000 shares having been 
granted at an exercise price of $17.50 per share.
PART II

                               INFORMATION REQUIRED IN
                              THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

     The following documents, which have been filed by Serologicals Corporation 
a Delaware corporation (the "Registrant"), with the Securities and Exchange 
Commission (the "Commission"), are incorporated herein by reference:

     (a) The Registrant's Annual Report on Form 10-K for the period ended 
December 31, 1996.

     (b) The Registrant's Quarterly Report on Form 10-Q for the period ended 
March 31, 1997.

     (c) The Registrant's Quarterly Report on Form 10-Q for the period ended 
June 30, 1997.

     (d) The Registrant's Quarterly Report on Form 10-Q for the period ended 
September 30, 1997.

     (e) The description of the Registrant's Common Stock, par value $0.01 per 
share, which is contained in a registration statement filed under Section 12 of 
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including 
any amendment or report filed for the purpose of updating such description.

     In addition, all documents subsequently filed by the Registrant pursuant 
to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing 
of a post-effective amendment which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold, shall be 
deemed to be incorporated by reference in this registration statement and to be
a part hereof from the time of filing of such documents.  Any statement 
contained in the documents incorporated or deemed to be incorporated by 
reference herein shall be deemed to be modified or superseded for purposes of 
this registration statement to the extent that a statement contained herein or 
in any other subsequently filed document which also is incorporated or deemed 
to be incorporated by reference herein modifies or supersedes such statement.  
Any such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this registration statement.

Item 4.  Description of Securities.

Not applicable.

Item 5.  Interest of Named Experts and Counsel. 

Not applicable.

Item 6.  Indemnification of Directors and Officers.

    The indemnification of officers and directors of the Registrant is governed 
by Section 145 of the General Corporation Law of the State of Delaware (the
"DGCL") and the Amended and Restated Certificate of Incorporation of the 
Registrant. Among other things, the DGCL permits indemnification of a director, 
officer, employee or agent in civil, criminal, administrative or investigative 
actions, suits or proceedings (other than an action by or in the right of the 
corporation) to which such person is a party or is threatened to be made a 
party by reason of the fact of such relationship with the corporation or the 
fact that such person is or was serving in a similar capacity with another 
entity at the request of the corporation against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him if such person acted in good faith and in a manner he 
reasonably believed to be in or not opposed to the best interests of the 
corporation, and, with respect to any criminal action or proceeding, if he had
no reasonable cause to believe his conduct was unlawful. No indemnification may
be made in any such suit to any person adjudged to be liable to the corporation
unless and only to the extent that the Delaware Court of Chancery or the court
in which the action was brought determines that, despite the adjudication of 
liability, such person is under all circumstances, fairly and reasonably 
entitled to indemnity for such expenses which such court shall deem proper.  
Under the DGCL, to the extent that a director, officer, employee or agent is 
successful, on the merits or otherwise, in the defense of any action, suit or 
proceeding or any claim, issue or matter therein (whether or not the suit is 
brought by or in the right of the corporation), he shall be indemnified against
expenses (including attorneys' fees) actually and reasonably incurred by him. 
In all cases in which indemnification is permitted (unless ordered by a court),
it may be made by the corporation only as authorized in the specific case upon 
a determination that the applicable standard of conduct has been met by the 
party to be indemnified.  The determination must be made by a majority vote of 
a quorum consisting of the directors who were not parties to the action or, if 
such a quorum is not obtainable, or even if obtainable, if a quorum of dis-
interested directors so directs, by independent legal counsel in a written 
opinion, or by the shareholders.  The statute authorizes the corporation to pay
expenses incurred by an officer or director in advance of a final disposition 
of a proceeding upon receipt of an undertaking by or on behalf of the person to
whom the advance will be made, to repay the advances if it shall ultimately be 
determined that he was not entitled to indemnification.  The DGCL provides that
indemnification and advancement of expenses permitted thereunder are not to be 
exclusive of any rights to which those seeking indemnification or advancement 
of expenses may be entitled under any By-law, agreement, vote of stockholders 
or disinterested directors, or otherwise.  The DGCL also authorizes the 
corporation to purchase and maintain liability insurance on behalf of its 
directors, officers, employees and agents regardless of whether the corporation
would have the statutory power to indemnify such persons against the 
liabilities insured.

     The Amended and Restated Certificate of Incorporation of the Registrant, 
as amended (the "Certificate"), provides that no director of the Registrant 
shall be personally liable to the Registrant or its stockholders for monetary
damages for breach of fiduciary duty as a director except for liability (i) for
any breach of the director's duty of loyalty to the Registrant or its stock-
holders, (ii) for acts or omissions not in good faith or which involve 
intentional misconduct or a knowing violation of law, (iii) for paying a 
dividend or approving a stock repurchase in violation of Section 174 of the 
DGCL or (iv) for any transaction from which the director derived an improper 
personal benefit.

     In addition, the Certificate provides that directors, officers and others 
shall be indemnified to the fullest extent authorized by the DGCL, as in effect 
(or, to the extent indemnification is broadened, as it may be amended), against 
any and all expense, liability and loss (including settlement) reasonably 
incurred or suffered by such person in connection with such service.  The 
Certificate further provides that, to the extent permitted by law, expenses so 
incurred by any such person in defending any such proceeding shall, at his
request, be paid by the Registrant in advance of the final disposition of such 
action or proceeding.

     The Certificate provides that the right to indemnification and the payment 
of expenses incurred in defending a proceeding in advance of its final 
disposition shall not be exclusive of any other right which any person may have 
or acquire under any law, provision of By-laws or otherwise.

     Pursuant to indemnification agreements with certain of its executive 
officers and directors the Registrant has agreed to indemnify such persons 
(including their respective heirs, executors and administrators) to the fullest 
extent permitted by the DGCL against all expenses and liabilities reasonably 
incurred in connection with or arising out of any action, suit or proceeding in 
which such executive officer or director may be involved by reason of having 
been a director or officer of the Registrant or any subsidiary thereof.

     The Registrant maintains directors and officers liability and company 
reimbursement insurance which, among other things (i) provides for payment on 
behalf of its officers and directors against loss as defined in the policy 
stemming from acts committed by directors and officers in their capacity as 
such and (ii) provides for payment on behalf of the Registrant against such 
loss but only when the Registrant shall be required or permitted to indemnify 
directors or officers for such loss pursuant to statutory or common law or 
pursuant to duly effective certificate of incorporation or by-law provisions.

Item 7.  Exemption from Registration Claimed.

         Not Applicable.

Item 8.  Exhibits

         The following exhibits are filed as part of this registration 
statement:

         4.1   Form of Option Agreement

         5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

        23.1   Consent of Arthur Andersen LLP.

        23.2   Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included
               in Exhibit 5.1).

        24     Power of Attorney (included in signature page to this 
               registration statement).

Item 9. Undertakings.

         (a)   The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being 
          made, a post-effective amendment to this registration statement:

                  (i)  To include any prospectus required by section 10(a)(3) 
                       of the Securities Act of 1933;

                  (ii) To reflect in the prospectus any facts or events arising 
                       after the effective date of the registration statement 
                       (or the most recent post effective amendment thereof) 
                       which, individually or in the aggregate, represent a 
                       fundamental change in the information set forth in the 
                       registration statement.  Notwithstanding the foregoing, 
                       any increase or decrease in volume of securities offered 
                       (if the total dollar value of securities offered would 
                       not exceed that which was registered) and any deviation 
                       from the low or high end of the estimated maximum 
                       offering range may be reflected in the form of 
                       prospectus filed with the Commission pursuant to Rule 
                       424(b) if, in the aggregate, the change in volume and 
                       price represent no more than a 20% change in the maximum
                       aggregate offering price set forth in the "Calculation 
                       of Registration Fee" table in the effective registration
                       statement;

                 (iii) To include any material information with respect to the 
                       plan of distribution not previously disclosed in the 
                       registration statement or any material change to such 
                       information in the registration statement;

     provided, however, that paragraphs (a)(l)(i) and (ii) do not apply if the 
     registration statement is on Form S-3 or S-8 and the information required 
     to be included in a post-effective amendment by those paragraphs is 
     contained in periodic reports filed by the Registrant pursuant to section 
     13 or Section 15(d) of the Securities Exchange Act of 1934 that are 
     incorporated by reference in the registration statement. 

         (2) That, for the purpose of determining any liability under the 
     Securities Act of 1933, each such post-effective amendment shall be deemed 
     to be a new registration statement relating to the securities offered 
     therein, and the offering of such securities at that time shall be deemed 
     to be the initial bona fide offering thereof.

         (3) To remove from registration by means of a post-effective amendment 
     any of the securities being registered which remain unsold at the 
     termination of the offering.

     (b)  The undersigned Registrant hereby undertakes that, for the purposes 
of determining any liability under the Securities Act of 1933, each filing of 
the Registrant's annual report pursuant to Section 13(a) or 15(d) of the 
Securities Exchange Act of 1934 (and, where applicable, each filing of an 
employee benefit plan's annual report pursuant to Section 15(d) of the 
Securities Exchange Act of 1934) that is incorporated by reference in the 
registration statement shall be deemed to be a new registration statement 
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     (h)  Insofar as indemnification for liabilities arising under the 
Securities Act of 1933 may be permitted to directors, officers and controlling 
persons of the Registrant pursuant to the foregoing provisions, or otherwise, 
the Registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed 
in the Act and is, therefore, unenforceable. In the event that a claim for 
indemnification against such liabilities (other than the payment by the 
Registrant of expenses incurred or paid by a director, officer or controlling 
person of the Registrant in the successful defense of any action, suit or 
proceeding) is asserted by such director, officer or controlling person in 
connection with the securities being registered, the Registrant will, unless in 
the opinion of its counsel the matter has been settled by controlling 
precedent, submit to a court of appropriate jurisdiction the question whether 
such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant 
certifies that it has reasonable grounds to believe that it meets all the 
requirements for filing on Form S-8 and has duly caused this Registration 
Statement to be signed on its behalf by the undersigned, hereunto duly 
authorized, in the City of Clarkston, State of Georgia, on this 5th day of 
March, l998.

                                              SEROLOGICALS CORPORATION

                                              By: /s/ Harold J. Tenoso       
                                                 -----------------------
                                                 Harold J. Tenoso, Ph.D.
                                                 President, Chief Executive 
                                                 Officer and Director

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned whose 
signature appears below constitutes and appoints Harold J. Tenoso, Ph.D. and 
Russell H. Plumb, and each of them (with full power of each of them to act 
alone), his true and lawful attorneys-in-fact, with full power of substitution 
and resubstitution for him and on his behalf, and in his name, place and stead, 
in any and all capacities to execute and sign any and all amendments or post-
effective amendments to this registration statement, and to file the same, with 
all exhibits thereto, and other documents in connection therewith, with the 
Securities and Exchange Commission, hereby ratifying and confirming all that 
said attorneys-in-fact or any of them or their or his substitute or 
substitutes, may lawfully do or cause to be done by virtue hereof and the 
Registrant hereby confers like authority on its behalf.

     Pursuant to the requirements of the Securities Act of 1933, the 
Registration Statement has been signed below by the following persons on behalf 
of the Registrant and in the capacities and on the dates indicated.

      Signature                     Title                       Date

/s/ Harold J. Tenoso       President, Chief Executive Officer  
Harold J. Tenoso, Ph.D.    and Director (Principal Executive  March 5, 1998
                            Officer

/s/ Samuel A. Penninger    Chairman of the Board of Directors  
Samuel A. Penninger, Jr.                                      March 5, 1998

/s/ James L. Currie        Director         
James L. Currie                                               March 5, 1998

/s/ Wade Fetzer            Director         
Wade Fetzer III                                               March 5, 1998

/s/ George M. Shaw         Director         
George M. Shaw                                                March 5, 1998

/s/ Lawrence E. Tilton     Director         
Lawrence E. Tilton                                            March 5, 1998

/s/ Matthew C. Weisman     Director         
Matthew C. Weisman                                            March 5, 1998

/s/Russell H. Plumb        Vice President, Finance and
Russell H. Plumb           and Administration and Chief       March 5, 1998
                           Financial Officer (Principal
                           Financial and Accounting Officer)
SEROLOGICALS CORPORATION
                             FORM S-8
                        REGISTRATION STATEMENT

                            EXHIBIT INDEX
                            -------------
                                                                Sequentially
                                                                Numbered
Exhibit                                                         Page
                                                                
4.1   Form of Option Agreement.

5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

23.1  Consent of Arthur Andersen LLP.

23.2  Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included in 
      Exhibit 5.1).

24    Power of Attorney (included in signature page to this registration 
      statement).